Tech Company Financing Transactions
ImmunoFree Funding Round
On 1/30/2024, ImmunoFree secured financing from National Kidney Foundation.
Transaction Overview
Company Name
Announced On
1/30/2024
Transaction Type
Debt
Amount
Unknown
Round
Undisclosed
Investors
National Kidney Foundation (Kevin Longino)
Proceeds Purpose
The fund will support ImmunoFree, a pioneering biomedical company dedicated to reshaping the landscape of organ transplantation by eliminating the need for immunosuppressive medications.
Company Information
Company Status
Private & Independent
Industry
Healthcare Services
Mailing Address
Undisclosed
New York, NY Undisclosed
USA
New York, NY Undisclosed
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
ImmunoFree was founded in 2023 to improve the lives of transplant patients by using new stem cell technology to eliminate the need for immunosuppressive medications.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Garet Hil
Browse more venture capital transactions:
Prev: 1/30/2024: Alchemist Accelerator venture capital transaction
Next: 1/30/2024: HDM Solar venture capital transaction
Share this article
News on VC Transactions
We do our best to report on every notable VC transaction. All VC database entries on this site are sourced from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs